BCG (Bacillus Calmette-Guérin)
BCG (Bacillus Calmette-Guérin)
BCG (Bacillus Calmette-Guérin)
BCG (Bacillus Calmette-Guérin)
BCG (Bacillus Calmette-Guérin)
BCG (Bacillus Calmette-Guérin) can be used in the treatment of non-invasive urothelial bladder carcinoma. Bilthoven Biologicals produces BCG exclusively for a third party as treatment against bladder cancer.1
BCG stimulates the immune system and has anti-tumour activity. Study data suggest that BCG works as a non‑specific immune booster, not through a single mechanism, but through several effects involving the cells of the immune system.1
BCG (Bacillus Calmette-Guérin)
BCG (Bacillus Calmette-Guérin) can be used in the treatment of non-invasive urothelial bladder carcinoma. Bilthoven Biologicals produces BCG exclusively for a third party as treatment against bladder cancer.1
BCG stimulates the immune system and has anti-tumour activity. Study data suggest that BCG works as a non‑specific immune booster, not through a single mechanism, but through several effects involving the cells of the immune system.1
Bladder cancer
Bladder cancer is the ninth most common cancer type worldwide. Bladder cancer is one of the most challenging cancers to diagnose and treat. Its diagnosis relies mainly on cystoscopy, an invasive procedure.2
When diagnosed at an early stage, bladder cancer is highly treatable, however 25% of bladder cancers are diagnosed at later stages.2
Bladder cancer
Bladder cancer is the ninth most common cancer type worldwide. Bladder cancer is one of the most challenging cancers to diagnose and treat. Its diagnosis relies mainly on cystoscopy, an invasive procedure.2
When diagnosed at an early stage, bladder cancer is highly treatable, however 25% of bladder cancers are diagnosed at later stages.2
Bladder cancer
Bladder cancer is the ninth most common cancer type worldwide. Bladder cancer is one of the most challenging cancers to diagnose and treat. Its diagnosis relies mainly on cystoscopy, an invasive procedure.2
When diagnosed at an early stage, bladder cancer is highly treatable, however 25% of bladder cancers are diagnosed at later stages.2
Bladder cancer
Bladder cancer is the ninth most common cancer type worldwide. Bladder cancer is one of the most challenging cancers to diagnose and treat. Its diagnosis relies mainly on cystoscopy, an invasive procedure.2
When diagnosed at an early stage, bladder cancer is highly treatable, however 25% of bladder cancers are diagnosed at later stages.2
Sources
1. Summary of Product Characteristics BCG-Medac, December 2024
2. International Agency for Research on Bladder Cancer, https://www.iarc.who.int/cancer-type/bladder-cancer/, accessed on 2 April 2026
Sources
1. Summary of Product Characteristics BCG-Medac, December 2024
2. International Agency for Research on Bladder Cancer, https://www.iarc.who.int/cancer-type/bladder-cancer/, accessed on 2 April 2026
Report Side Effects
If you experience any side effects when using BCG (Bacillus Calmette-Guérin), please report them to help us ensure product safety and monitor adverse reactions.
Report Side EffectsReport Side Effects
If you experience any side effects when using BCG (Bacillus Calmette-Guérin), please report them to help us ensure product safety and monitor adverse reactions.
Report Side Effects